Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

Q: The story not only mentions the cost of a scan to individuals ($100 to $500), it also notes that about $50 million dollars was spent on this type of scanning nationwide in 2008. A longer story could have also reported on the costs of additional testing and treatments triggered by screening apparently healthy individuals. As mentioned above, the story notes that while some experts recommend CT screening for coronary artery calcium deposits in order to increase the number of people receiving treatment to reduce the likelihood of a heart, others are skeptical about the real value of this type of screening for apparently health people. The reporter points out that many heart attacks strike people who do not have very high cholesterol levels or other indicators of elevated risk, but also that "no study has linked the use of CT scans with better patient outcomes." The potential cancer risk caused by CT screening for signs of heart disease is the point of this story. Also, by highlighting uncertainty about the benefits of the screening and recapping debate over the Texas law mandating coverage of the scans, the story emphasizes the importance of considering potential harms when setting public policy on screening tests. A longer story could have considered other potential harms, including the side effects of treatments prescribed based on screening tests. The story does a good job of summarizing the results of this study of potential cancer risk from CT screening. In addition, it outlines the positions of experts and organizations on the broader body of evidence on the use of CT scans to identify people who may have plaque buildups in their heart arteries. It would have been better if the reporter stated that the estimate was based on several assumptions, that it wasn't a definitive point estimate, but just the center of a range, and that it was higher than earlier estimates. Readers still got the point that there is a cancer risk which needs to be considered. The story notes that heart disease is the leading cause of death in the U.S., but it also points out doubts about whether screening with CT scans for calcium buildup in heart arteries can reduce the toll. The story includes experts and advocates that represent the key perspectives in debate about CT screening for calcium deposits in coronary arteries. However, it does not include information on possible conflicts of interest. Although this story points out that alternative screening techniques are available and it makes reference to cholesterol, it does not include any details about the alternatives. The story says that the CT scanners used for this test are "all over the city" and included an estimate that in 2008 about 200,000 people around the country were scanned for calcium buildups in their coronary arteries. not in question in this story The story includes quotes from independent experts and other information that was not in the news release about the journal article.

A: Warning sounded on heart scan law
****
Q: The story does not mention the cost of adult male circumcision outside of a clinical trail. It is also not clear whether this is a reimbursible procedure for adult males in the USA when no acute problem exists. The story appropriately describes the design of the two similar studies and provides both absolute and relative evidence that male circumcision reduces a man's risk of acquiring HIV via heterosexual sex. The story also mentions that the trials were stopped early because the benefit of male circumcision so significantly reduced the risk of acquiring HIV that it would be unethical to continue a trial in which uncircumcised men were not offered this protection. What is not mentioned is that the absolute number of avoided infections will be low in lower prevalence populations, so the risks of complications may outweigh the potential benefits for an individual of low risk. The story mentions potential harms of male circumcision such as mild infections. These are treatable and rare, especially when the procedure is performed by a trained medical professional. However, it is difficult to assess the negative consequences of surgery as no publication of adverse events is reviewable. It is also possible that side effects or negative consequences in the real-world (rather than a clinical trial) would be more common. The story doesn't explain whether there was a placebo arm of the study. Was there a sham operation? If so, were patients and evaluators blinded regarding treatment? This is a key indicator of study quality that is not commented upon. (Onecould positthat there is a reduced frequency of sexual encounters after this surgery, and this is the critical predictor of reduced acquisition of HIV, not the surgery itself.) The story does not engage in disease mongering. The story quotes an NIH official for perspective on the results of these studies. But since the NIH sponsored the study, he does have an interest in its outcome. It also quoted representatives of the World Health Organization and the Global AIDS Alliance. There are experts who would disagree with public health-related mass circumcision programs, for reasons both cultural and related to quality of life. The story mentions male circumcision as one method of reducing the transmission of HIV. But the story also mentions safer sex practices such as using condoms for better protection against HIV. The story reports on two large studies of male circumcision and reduced HIV in African heterosexual men. We are not told if these studies have been reviewed in a peer-reviewed journal or where they will be published. The results of these studies may be applicable regardless of geography: While more male infants are routinely circumcised in the U.S. than in Africa, this surgery is available for uncircumcised adult men in the U.S. who wish to reduce their risk of HIV transmission from heterosexual sex. Other protection against theHIV is still necessary. The story does note that this is a routine surgical procedure with few compilcations. What is stressed in the press release, but not the article, is that this procedure should only be performed by a medical professional who can also provide appropriate post-operative care during the healing period. Availability of safe circumcision and safe postoperative care is far from certain around the world. It is clear from the story that the link between male circumcision and HIV prevention was noted as long ago as the late 1980s. The story used several independent experts for comment, so it appears unlikely that it relied solely or largely on a news release.

A: Two studies in Africa link male circumcision to lower risk of HIV
****
Q: On 18 February 2017, the SpaceX space transport service will launch a capsule to the International Space Station for a resupply mission (CRS-10) aboard a Falcon 9 rocket. Among the items contained within the capsule will be a sample of the highly infectious Methicillin-resistant Staphylococcus aureus (MRSA) bacterium, along with a device able to monitor that sample at the genomic level. This experiment is the result of the first "Galactic Grant Competition," a Center for the Advancement of Science in Space (CASIS) initiative aimed at providing Massachusetts-based biotech companies access to the International Space Station. Among the grant recipients was Harvard physicist Anita Goel's private research company Nanobiosym, which has developed a mobile pathogen-detection tool that has the potential to detect genetic mutations to bacterial infections in real time. This "tricorder"-style device, dubbed Gene-RADAR by Nanobiosym, is described as follows in a patent filing: A portable system for extracting, optionally amplifying, and detecting nucleic acids or proteins using a compact integrated chip in combination with a mobile device system for analyzing detected signals. With the receipt of the CASIS grant, Nanobiosym was given the opportunity to refine the technology in space. Not only will this help with the development that technology, but it may also allow scientists to view genetic mutations to bacterial in "fast-forward", helping scientists predict the ways in which bacterial infections develop antibiotic resistance, as described in the NASA mission summary: Microgravity may accelerate the rate of bacterial mutations and this pilot investigation analyzes this process in two strains aboard the International Space Station, which may provide insight into how deadly bacteria become drug-resistant. The data can help refine models of drug resistance and support development of better medicines to counter it. This conclusion is far from settled science, as described in a 2015 review paper,but both space-based and low-gravity simulation experiments have demonstrated that it is at least plausible that low gravity affects the mutation rate of some bacterial species: There is general agreement that microgravity represents the major influence on bacterial growth kinetics and bacterial cell behavior during short orbital flights, although radiation may increase microbial mutation rates during flight [as well]. If, as Goel hypothesizes, mutations rates speed up in space, Scientists may be able to use this information to develop drugs that anticipate potential mechanisms of antibiotic resistance before they occur, as described in a CASIS press release: The project will attempt to computationally predict bacterial mutations, to evaluate model organisms in space, and to use the empirical results to validate and refine the company's predictive algorithms. This proof-of-concept experiment will provide data that can be applied to future predictive models for antibiotic resistant pathogen mutations, which will be of significant value to antibiotic drug development.

A:
SpaceX will be transporting a potentially deadly pathogen to the International Space Station as part of their next launch.
****